Freenome
Biotech developing blood-based early cancer detection (multiomics + AI), e.g. its SimpleScreen CRC colorectal test. Founded 2014, Brisbane CA. ~400 staff. Went public via SPAC in 2026.
★
★
★
★
★
New
(0 reviews)
Brisbane, CA, USA (lab/clinical on-site; corporate/tech some remote)
HQ
400
employees
2014
founded